Siren »

AgomAb Therapeutics NV shares owned by Siren

Quarter-by-quarter ownership of AgomAb Therapeutics NV (AGMB) shares owned by Siren from 13F filings

Historical chart of Siren investment in AgomAb Therapeutics NV

Tip: Access up to 7 years of quarterly data

All positions including AgomAb Therapeutics NV held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AgomAb Therapeutics NV by Siren

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.3M 411k 10.49

More positions owned by Siren

Scholar Rock Hldg Corp (SRRK)
Kymera Therapeutics (KYMR)
Erasca (ERAS)
Edgewise Therapeutics (EWTX)
BeOne Medicines Sponsored Ads (ONC)
Tango Therapeutics (TNGX)
Bicara Therapeutics (BCAX)
Revolution Medicines (RVMD)
Arrowhead Pharmaceuticals (ARWR)
Veradermics Common Stock (MANE)
Xenon Pharmaceuticals (XENE)
Olema Pharmaceuticals (OLMA)
Crinetics Pharmaceuticals In (CRNX)
Lexicon Pharmaceuticals Com New (LXRX)
Cogent Biosciences (COGT)

View all positions for Siren

Top funds holding AgomAb Therapeutics NV

EQT Fund Management S.a r.l.
Sanofi
Cormorant Asset Management
TCG Crossover Management
Federated Investors
Casdin Capital
Andera Partners
FMR
Nantahala Capital Management
Standard Life Aberdeen
Perceptive Advisors
Samsara BioCapital
Siren
LMR Partners
Seven Grand Managers

View all funds holding AgomAb Therapeutics NV